About Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
During the past decade, Policlinico Universitario Campus Biomedico UOC di Oncologia Medica conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
According to Clinical.Site data, the most researched conditions in "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica" are
"Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica" in a lesser frequency.
Clinical Trials Intervention Types at Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
Most popular intervention types in "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab control" (1 trials), "Bevacizumab experimental" (1 trials), "Capecitabine" (1 trials), "Trifluridine/Tipiracil hydrochloride (S95005)" (1 trials) and "Trifluridine/tipiracil hydrochloride (S95005)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
The vast majority of trials in "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica" are
2 trials for "All" genders.
Clinical Trials Status at Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
Currently, there are NaN active trials in "Policlinico Universitario Campus Biomedico UOC di Oncologia Medica".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Policlinico Universitario Campus Biomedico UOC di Oncologia Medica,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Policlinico Universitario Campus Biomedico UOC di Oncologia Medica, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".